Yovis: Bacterial Fingerprint campaign wins the Consumer Health Category at the Life Science Excellence Awards
Among the top 10 also A_MAB in the HR category. To Alfathon goes the Best PR & Communication project....
Read more
Sulodexide in EVF Guidelines for Prevention of Post-Thrombotic Syndrome (PTS)
New EVF Guidelines publication entitled Management of CVD of lower limbs – Part II reports Sulodexide scientific evidences in the dedicated chapter to Prevention of Post-Thrombotic Syndrome, definin...
Read more
Brilacidin, license agreement with Innovation Pharmaceuticals
Innovation Pharmaceuticals announces License Agreement with Alfasigma S.p.A. for the development and commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis....
Read more
Alfasigma USA Acquires Zelnorm™
Alfasigma USA has acquired the brand ZELNORM (tegaserod), a treatment for IBS-C, from Sloan Pharma, with the aim to relaunch the brand in the United States....
Read more